Description
Semaglutide reduces blood glucose in a glucose dependent manner by simulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying. During hypoglycemia, Semaglutide diminishes insulin secretion and does not impair glucagon secretion. Semaglutide reduces body weight and body fat mass by an overall reduced appetite.
Research suggests Ozempic supports weight loss of around 1kg or around 1.1% of body weight after one month. After two months, it’s around 2kg or 2.2% of body weight. Most people started losing weight within the first 4 weeks, but some took longer.
Reviews
There are no reviews yet.